Selected Abstracts
Clinical Nephrology
Reduced circulatory volume/sepsis/hepatorenal
c
Is the administration of dopamine associated with adverse outcomes in
acute renal failure?
c
The role of loop diuretics in acute renal failure? A double-
blind, randomised controlled trial
Cyclosporine, ARF in transplant patients
c
Thyroid hormone for treatment of acute tubular necrosis in
renal allografts: a prospective, randomized trial
Embolic disease
c
Focal segmental glomerulosclerosis due to cholesterol atheroembolic
disease: Clinicopathologic correlations
Acute glomerulonephritis/RPGN
c
Effect of initial histology and plasmapheresis treatment on
prognosis in RPGN: results of the German prospective randomized
multicenter study
c
Superantigen-related glomerulonephritis and vasculitis due to MRSA
infection
Acute interstitial nephritis/NSAID
c
Renal gallium scintigraphy helps decision-making in acute renal
failure
Radiocontrast media
c
Effect of hemodialysis after contrast media application in
adults with renal insufficiency
Post surgical
c
Acute renal failure following cardiac surgery
Urinary tract obstruction
c
Distinctive effects between obstructive and non-obstructive
pyelocaliectasis by duplex-Doppler ultrasonography
Infections (other than hepatitis, peritonitis)
c
Outcome of HIV-infected patients on hemodialysis
Hereditary polycystic disease
c
Autosomal dominant polycystic kidney disease patients are at risk for
recurrent intracranial aneurysms
c
Rate of loss of renal function in hypertensive and normotensive
autosomal dominant polycystic kidney disease patients
Hyperkalemia
c
Trimethoprim/sulfamethoxazole in standard dose causes
hyperkalemia
c
Hyporeninemia is associated with erythropoietin deficiency in
type I diabetic patients
c
Examination for the thiazide-sensitive Na-Cl cotransporter as a
candidate gene in Gordon's syndrome
Renal biopsy techniques, tips, complications
c
Bleeding time does not predict bleeding complications post
renal biopsy
c
Timing of complications in percutaneous renal biopsy: what is
the optimal period of observation?
Diabetes
c
Effect of nondihydropyridine calcium antagonists on progression of
nephropathy from non-insulin dependent diabetics: a five year
follow-up study
c
The ACE gene polymorphism in patients with diabetic nephropathy
c
Short-term comparison of ACE inhibition vs. calcium channel blockade
in African Americans with type II diabetic nephropathy
c
Long-term effect of captopril on kidney function in normotensive
insulin-dependent diabetic patients with diabetic nephropathy
c
Correlates of diabetic and non-diabetic renal disease in NIDDM
c
Smoking -- a major predictor of nephropathy in newly diagnosed type
II diabetes
c
Kidney/pancreas transplant versus kidney transplant alone
c
Efficacy of captopril in normotensive diabetic patients with
microalbuminuria - 8 years follow up
c
Progression of overt diabetic nephropathy: Role of metabolic control
c
Glomerular structure in long term type II diabetes with and
without microalbuminuria
c
Cyclosporine nephrotoxicity in insulin-dependent diabetic
patients: an eight year follow up
c
Renal production of TGF-beta is increased in diabetic patients
c
Progression of diabetic nephropathy and the insertion/deletion
polymorphismof the ACE gene
Focal, collapsing, fibrillary GN
c
The impact of plasmapheresis on recurrent focal glomerular
sclerosis in renal allografts
c
Results of a 6 month randomized control trial of cyclosporine versus
placebo in adults with steroid-resistant, idiopathic, focal segmental
glomerulosclerosis
c
Glomerular number in focal segmental glomerulosclerosis and
minimal change nephrotic syndrome
IgA Nephropathy
c
The deletion polymorphism in the ACE gene is a risk factor for the
progression to renal failure independent of the M235T polymorphism in
the angiotensinogen gene
c
A family history of hypertension is associated to
nephrosclerosis and predicts the future onset of hypertension in
patients with IgA nephropathy
Hepatitis-associated nephropathy
c
Infection with hepatitis C virus increases the risk of de novo
glomerulonephritis in renal transplant recipients
c
Serological and virological profiles in renal transplant
candidates
c
Liver histology in renal transplant patients after more than 10
years of HCV infection
c
Localization of HCV in renal tissue of HCV-infected patients with
cryoglobulinemic mesangiocapillary glomerulonephritis: an immuno-
histochemical study
c
Glomerular disease in HIV-infected patients with hepatitis C
virus
HIV-associated nephropathy
c
Clinicopathologic evaluation of prednisone treatment or patients with
HIV nephropathy
c
Response to early and prolonged inhibition of angiotensin converting
enzyme in HIV-associated nephropathy
c
HIV/AIDS as a cause of renal failure
c
Contribution of globulins to plasma oncotic pressure and the
presence of edema in HIV patients with proteinuria
c
Cryoglobulinemia in HIV-infected patients with renal disease
c
Captopril increases renal survival in patients with HIV
nephropathy
c
Absence of edema in HIV-infected patients with ESRD
c
Prednisone ameliorates the progression on HIV-associated
nephropathy
c
Decreasing incidence of severe acute renal failure in patients with
HIV infection
c
Renal disease prevalence and risk factors among HIV-infected
inner city residents
c
Are we missing an epidemic of HIV-associated nephropathy?
Lupus nephritis
c
Renal lesions in drug induced lupus syndromes
Membranous GN
c
Changing incidence of idiopathic glomerular diseases in adults
c
Therapy of membranous glomerulonephritis with nephrotic syndrome. Five
year follow-up of a prospective, randomized study
c
Urinary C5b-9 in early and advanced renal insufficiency in
membranous nephropathy
Vasculitis (Wegener's PAN, etc.)
c
Assessing the severity of renal disease in systemic vasculitis: how to
the histopathologic data predict renal outcome?
c
Prevention of relapses in systemic vasculitis
c
ANCA-associated vasculitis and renal involvement: preliminary results
of a prospective randomized study comparing daily oral versus monthly I.V.
cyclophosphamide application
c
Humanized monoclonal antibody therapy for Wegener's
granulomatosis
c
Prevention of relapses of Wegener's granulomatosis by treatment with
co-trimoxazole. A placebo controlled trial.
c
Outcome of children with ANCA positive glomerulonephritis
Renal Stones: Diagnosis
c
Primary hyperoxaluria types I and II: clinical and lithogenic features
Renal Stones: Etiology
c
Decreased bone formation in idiopathic hypercalciuric calcium stone
formers explains reduced bone density
c
A prospective study of dietary and supplemental calcium and the risk
of kidney stones in women
Use back arrow on your browser to go back to HDCN home page (faster)
or click on the arrow.